Antibody-Drug Conjugates (ADCs) are targeted cancer therapies that combine an antibody specific to cancer cells with a potent anti-cancer drug. By delivering the drug directly to tumor cells, Antibody-Drug Conjugates (ADCs) minimize damage to healthy tissue, enhance treatment effectiveness, and offer a more precise approach for treating various cancers.